Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Huaying Ruan"'
Publikováno v:
IEEE Access, Vol 12, Pp 177491-177503 (2024)
Technology-driven startups often experience fluctuations in business volume and their delivery peak exceeds the conventional functional department’s human resource staffing. Resource allocation is crucial for ensuring timely completion of project d
Externí odkaz:
https://doaj.org/article/cbea7711e233490898e5e8846a88ee81
Autor:
Min Yang, Kang Yu, Siguo Hao, Songfu Jiang, Linjun Chen, Jie Jin, Wei Wang, Zonghai Li, Jun Xiao, Huaying Ruan
Publikováno v:
Blood. 132:960-960
Introduction: B Cell Mature Antigen (BCMA)-targeted chimeric antigen receptor T (CAR-T) cell therapy emerges as promising treatment for patients with relapse/refractory multiple myeloma (RRMM). Previous studies indicate patients who receive high-dose
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e2c4a318049efcc15eb448e513e33ede
https://doi.org/10.1182/blood-2018-99-113220
https://doi.org/10.1182/blood-2018-99-113220
Autor:
Hua Jiang, Yuan Zhang, Huamao Wang, Huiping Gao, Donghua Shi, Huaying Ruan, Zonghai Li, Jiachang Chi, Qinhua Cindy Ru, Bo Zhai, Xingxing Qi
Publikováno v:
Journal of Clinical Oncology. 35:3049-3049
3049 Background: HCC was commonly diagnosed and identified as leading causes of cancer death in China. Using a 10% cutoff score, GPC3 was detected in 63.6% of HCCs. Safety and preliminary efficacy of a GPC3 CAR-T was evaluated in 13 Chinese patients
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8c5958d3e4de369cc2a1b2c84a69ea9b
https://doi.org/10.1200/jco.2017.35.15_suppl.3049
https://doi.org/10.1200/jco.2017.35.15_suppl.3049